Ozone enema: a model of microscopic colitis in rats.
Ozone is one of the most powerful oxidants available, with many applications in industry and medicine. Medically relevant features of ozone include bacterial and virucidal properties, disinfection, sterilization, circulatory stimulation, and disruption of malignant cells. Ozone therapy is administered in various ways, including intravenously, intramuscularly, and intrarectally. The latter modality is used for the treatment of colitis and hepatitis. Our aim was to examine the effect of ozone water enema on normal and inflamed rat colonic mucosa. Ozone water (20 microg/ml) was prepared via ozone generator and administered intrarectally (0.5 ml) daily. Rats were killed one, three, and seven days after rectal ozone water administration, and their colons resected, rinsed, and weighed (grams per 10 cm). Damage was assessed macro- and microscopically and tissue processed for myeloperoxidase and nitric oxide synthase activity. Rats receiving saline served as controls. In an additional experiment colitis was induced by intrarectal iodoacetamide. Ozone therapy caused no macroscopic damage. Ozone therapy induced microscopic colitis, which lasted for at least a week and was accompanied by increase in segmental weight, myeloperoxidase and nitric oxide activity, and prostaglandin E2 generation. Ozone therapy had no protective effect on inflamed mucosa. In conclusion, ozone water therapy had a deleterious effect on normal colonic mucosa, suggesting intrarectal administration be reevaluated. Ozone water enema may serve as a model of microscopic colitis.
Eliakim
R
R
Department of Medicine, Hadassah University Hospital, Jerusalem, Israel.
Karmeli
F
F
Rachmilewitz
D
D
Cohen
P
P
Zimran
A
A
D000285:Administration, Rectal; D000818:Animals; D003092:Colitis / Q000139:chemically induced* / Q000628:therapy*; D003106:Colon / Q000187:drug effects / Q000473:pathology; D015232:Dinoprostone / Q000378:metabolism; D004733:Enema; D007460:Iodoacetamide; D008297:Male; D019001:Nitric Oxide Synthase / Q000378:metabolism; D010126:Ozone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D009195:Peroxidase / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley
D010126:Ozone; D009195:Peroxidase; D019001:Nitric Oxide Synthase; D015232:Dinoprostone; D007460:Iodoacetamide